Lv54
980 积分 2024-03-07 加入
First‐in‐Human Regulatory Submissions
1个月前
已完结
Project Management and International Regulatory Requirements and Strategies for First‐in‐Human Trials
1个月前
已完结
Unique Considerations for Biopharmaceutics
1个月前
已完结
Exploratory INDs/CTAs
1个月前
已完结
Estimation of Human Starting Dose for Phase I Clinical Programs
1个月前
已完结
Good Laboratory Practice
1个月前
已完结
Toxicokinetics in Support of Drug Development
1个月前
已完结
Toxicology Program to Support Initiation of a Clinical Phase I Program for a New Medicine
1个月前
已完结
Nonclinical Safety Pharmacology Studies Recommended for Support of First‐in‐Human Clinical Trials
1个月前
已完结
Chemistry, Manufacturing, and Controls: The Drug Substance and Formulated Drug Product
1个月前
已完结
皖公网安备34019202002308
